Related Experiment Videos
Dermorphin-induced hyperexcitability in hippocampal CA3 and CA1 in vitro
L S Jones1, S Y Grooms, S Salvadori
1Department of Developmental Biology and Anatomy, University of South Carolina School of Medicine, Columbia 29208.
European Journal of Pharmacology
|October 13, 1994
Summary
Dermorphin enhances rat hippocampal CA3 responses at low doses, but high doses cause epileptiform activity. This suggests mu-opioid receptors modulate neural responses, but excessive activation can be proconvulsant.
Area of Science:
- Neuroscience
- Pharmacology
- Neurophysiology
Background:
- Dermorphin is a potent mu 1-opioid receptor agonist.
- Opioid receptors play a role in modulating neuronal activity.
- The hippocampus is crucial for learning and memory and is susceptible to epileptic activity.
Purpose of the Study:
- To investigate the effects of dermorphin on synaptic transmission in the rat hippocampus.
- To determine the dose-dependent effects of dermorphin on neuronal excitability.
- To explore the role of mu-opioid receptors in hippocampal function.
Main Methods:
- Electrophysiological recordings from rat hippocampal slices.
- Stimulation of Schaffer collaterals and mossy fibers.
- Application of varying concentrations of dermorphin and its analogue [L-Ala2]Dermorphin.
- Blockade of opioid receptors with naloxone.
Main Results:
- Low concentrations (50-100 nM) of dermorphin enhanced CA3 population responses to threshold stimulation.
- CA1 responses were less affected by low-dose dermorphin.
- High concentrations (500 nM) of dermorphin induced epileptiform activity and spontaneous bursting.
- The inactive analogue [L-Ala2]Dermorphin had no effect.
- Naloxone partially blocked dermorphin's effects.
Conclusions:
- Dermorphin acts as a facilitatory modulator of hippocampal responses at threshold levels via mu-opioid receptors.
- Excessive mu-opioid receptor activation by dermorphin can lead to proconvulsant effects in the hippocampus.
- These findings support in vivo observations on the dual role of mu-opioid receptors in the hippocampus.